The transCampus initiative aims to drive forward university partnership and collaborative research works between two of Europe’s leading academic institutions and partners of the i-PROGNOSIS project: King’s College London (KCL) and Technische Universität Dresden (TUD).
The main advantage of such an initiative lies in the formation of a “Star Alliance” which aims to bring the resources, critical mass and individual strengths of each institution together to create an even larger, united and complementary academic and clinical campus. The joint efforts of two leading universities in Europe will create a partnership of scientific strength in Biomedicine, able to compete with other leading institutions in the United States and across the rest of the globe.
Based on successful previous collaborations on wrist-worn accelerometers called Parkinson’s KinetiGraph, leading neurologists from KCL and TUD joined forced again to explore the non-motor syndrome of idiopathic Parkinson’s disease. In i-PROGNOSIS, both institutions jointly contribute to the development of a technology platform for early detection of Parkinson’s and human intervention studies.
“Following metabolic and diabetic exchange between our two institutions I am very happy that now neurodegenerative diseases are also part of our program“, says Heinz Reichmann, who is also Dean of the Carl Gustav Carus Faculty of Medicine at TU Dresden.